Dual Targeted CD20/19 CAR-T Cell Production Using the ClinimacsA® Prodigy System

被引：0
|
作者：
Shah, Nirav [1 ]
Zhu, Fenlu [2 ]
Xu, Huiqing [2 ]
Schneider, Dina [3 ]
Orentas, Rimas [3 ]
Dropulic, Boro [3 ]
Hari, Parameswaran [1 ]
Keever-Taylor, Carolyn [1 ]
机构：
[1] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[3] Lentigen Technol Inc, Gaithersburg, MD USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2017年 / 23卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
169
引用
收藏
页码：S141 / S141
页数：1
相关论文
共 50 条
  • [1] CAR-T Cell Production Using the Clinimacs® Prodigy System
    Zhu, Fenlu
    Shah, Nirav N.
    Xu, Huiqing
    Schneider, Dina
    Orentas, Rimas
    Dropulic, Boro
    Hari, Parameswaran
    Keever-Taylor, Carolyn A.
    BLOOD, 2016, 128 (22)
  • [2] Combating antigen escape with CD19/CD20 bispecific CAR-T cell therapy
    Zah, Eugenia
    Lin, Meng-Yin
    Jensen, Michael C.
    Silva-Benedict, Anne
    Chen, Yvonne Y.
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (03)
  • [3] Loop CD20/CD19 CAR-T cells eradicate B-cell malignancies efficiently
    Zhaoqi Chen
    Yan Liu
    Nianci Chen
    Haiyan Xing
    Zheng Tian
    Kejing Tang
    Qing Rao
    Yingxi Xu
    Ying Wang
    Min Wang
    Jianxiang Wang
    Science China(Life Sciences) , 2023, (04) : 754 - 770
  • [4] Loop CD20/CD19 CAR-T cells eradicate B-cell malignancies efficiently
    Chen, Zhaoqi
    Liu, Yan
    Chen, Nianci
    Xing, Haiyan
    Tian, Zheng
    Tang, Kejing
    Rao, Qing
    Xu, Yingxi
    Wang, Ying
    Wang, Min
    Wang, Jianxiang
    SCIENCE CHINA-LIFE SCIENCES, 2023, 66 (04) : 754 - 770
  • [5] Loop CD20/CD19 CAR-T cells eradicate B-cell malignancies efficiently
    Zhaoqi Chen
    Yan Liu
    Nianci Chen
    Haiyan Xing
    Zheng Tian
    Kejing Tang
    Qing Rao
    Yingxi Xu
    Ying Wang
    Min Wang
    Jianxiang Wang
    Science China(Life Sciences), 2023, 66 (04) : 754 - 770
  • [6] Loop CD20/CD19 CAR-T cells eradicate B-cell malignancies efficiently
    Zhaoqi Chen
    Yan Liu
    Nianci Chen
    Haiyan Xing
    Zheng Tian
    Kejing Tang
    Qing Rao
    Yingxi Xu
    Ying Wang
    Min Wang
    Jianxiang Wang
    Science China Life Sciences, 2023, 66 : 754 - 770
  • [7] Manufacturing CD20/CD19-targeted iCasp9 regulatable CAR-TSCM cells using a Quantum pBac-based CAR-T engineering system
    Chang, Peter S.
    Chen, Yi-Chun
    Hua, Wei-Kai
    Hsu, Jeff C.
    Tsai, Jui-Cheng
    Huang, Yi-Wun
    Kao, Yi-Hsin
    Wu, Pei-Hua
    Wang, Po-Nan
    Chang, Yi-Fang
    Chang, Ming-Chih
    Chang, Yu-Cheng
    Jian, Shiou-Ling
    Lai, Jiann-Shiun
    Lai, Ming-Tain
    Yang, Wei-Cheng
    Shen, Chia-Ning
    Wen, Kuo-Lan Karen
    Wu, Sareina Chiung-Yuan
    PLOS ONE, 2024, 19 (08):
  • [8] CD20 Targeted CAR-T for High-Risk B-Cell Non-Hodgkin Lymphomas
    Shadman, Mazyar
    Gopal, Ajay K.
    Smith, Stephen D.
    Lynch, Ryan C.
    Ujjani, Chaitra S.
    Turtle, Cameron J.
    Greenbaum, Adam
    Redman, Mary
    Yeung, Cecilia
    Sersch, Martina
    Warren, Edus H.
    Maloney, David G.
    Till, Brian G.
    BLOOD, 2019, 134
  • [9] Closed-system manufacturing of CD19 and dual-targeted CD20/19 chimeric antigen receptor T cells using the CliniMACS Prodigy device at an academic medical center
    Zhu, Fenlu
    Shah, Nirav
    Xu, Huiqing
    Schneider, Dina
    Orentas, Rimas
    Dropulic, Boro
    Hari, Parameswaran
    Keever-Taylor, Carolyn A.
    CYTOTHERAPY, 2018, 20 (03) : 394 - 406
  • [10] Neurotoxicity Associated with CD19-Targeted CAR-T Cell Therapies
    Gust, Juliane
    Taraseviciute, Agne
    Turtle, Cameron J.
    CNS DRUGS, 2018, 32 (12) : 1091 - 1101
12345